These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3299308)

  • 41. The effect of maternal ketanserin treatment on foetal 5-HT receptor function in umbilical cord artery of pre-eclamptic patients.
    Hanff LM; Gupta S; MaassenVanDenBrink A; Steegers EA; Saxena PR; Vulto AG; Visser W
    Neonatology; 2007; 92(4):240-7. PubMed ID: 17556842
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differences in the acute and chronic antihypertensive mechanism of action of ketanserin in spontaneously hypertensive rats.
    Balasubramaniam G; Lee HS; Mah SC
    J Pharmacol Exp Ther; 1993 Jan; 264(1):129-34. PubMed ID: 8093720
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of hormone replacement therapy on arterial blood pressure and vascular compliance in postmenopausal women with arterial hypertension.
    Kawecka-Jaszcz K; Czarnecka D; Olszanecka A; Rajzer M; Jankowski P
    J Hum Hypertens; 2002 Jul; 16(7):509-16. PubMed ID: 12080436
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute effects of antagonist of S2-receptors.
    Petkovská N; Brimichová G; Tison P; Dzúrik R
    Czech Med; 1984; 7(4):210-4. PubMed ID: 6084584
    [TBL] [Abstract][Full Text] [Related]  

  • 45. On the mechanism of action of ketanserin, a selective antagonist of the S2 receptors with antihypertensive activity.
    Rión R; Mena MA; Hong E
    Proc West Pharmacol Soc; 1983; 26():373-5. PubMed ID: 6889366
    [No Abstract]   [Full Text] [Related]  

  • 46. LY53857, a selective and potent serotonergic (5-HT2) receptor antagonist, does not lower blood pressure in the spontaneously hypertensive rat.
    Cohen ML; Fuller RW; Kurz KD
    J Pharmacol Exp Ther; 1983 Nov; 227(2):327-32. PubMed ID: 6313898
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of serotonin1A and serotonin2 receptors in the central regulation of the cardiovascular system.
    McCall RB; Clement ME
    Pharmacol Rev; 1994 Sep; 46(3):231-43. PubMed ID: 7831380
    [No Abstract]   [Full Text] [Related]  

  • 48. Ketanserin in women with chronic hypertension and underlying thrombophilia.
    Banga FR; Bolte AC; Dekker GA; van Geijn HP
    Obstet Gynecol; 2004 May; 103(5 Pt 2):1084-7. PubMed ID: 15121616
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Blood pressure during a combination of ketanserin and hydrochlorothiazide.
    Ferrara LA; Fasano ML; Soro S; Farinaro E; Celentano E; Mancini M
    Int J Clin Pharmacol Res; 1987; 7(6):463-8. PubMed ID: 3440636
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Three distinct subtypes of serotonergic receptors mediate the triphasic blood pressure response to serotonin in rats.
    Kalkman HO; Engel G; Hoyer D
    J Hypertens Suppl; 1984 Dec; 2(3):S143-5. PubMed ID: 6599662
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 5-Hydroxytryptamine(2B) receptor function is enhanced in the N(omega)-nitro-L-arginine hypertensive rat.
    Russell A; Banes A; Berlin H; Fink GD; Watts SW
    J Pharmacol Exp Ther; 2002 Oct; 303(1):179-87. PubMed ID: 12235249
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Role of ketanserin--a serotonin antagonist--in the treatment of arterial hypertension].
    Mungiu OC
    Rev Med Chir Soc Med Nat Iasi; 1986; 90(3):559-60. PubMed ID: 3576002
    [No Abstract]   [Full Text] [Related]  

  • 53. [Prolonged treatment with ketanserin in essential hypertension and comparison with metoprolol].
    Finkielman S
    Medicina (B Aires); 1985; 45(4):447-9. PubMed ID: 3916016
    [No Abstract]   [Full Text] [Related]  

  • 54. [Serotonergic antagonist].
    Deguchi F; Saito T; Inagaki Y
    Nihon Rinsho; 1992 Apr; 50 Suppl():770-6. PubMed ID: 1635266
    [No Abstract]   [Full Text] [Related]  

  • 55. Insufficient efficacy of intravenous ketanserin in severe early-onset pre-eclampsia.
    Hanff LM; Visser W; Roofthooft DW; Vermes A; Hop WC; Steegers EA; Vulto AG
    Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):199-203. PubMed ID: 16386829
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The clinical significance of serotonin antagonists].
    Regenthal R; Voigt H
    Z Gesamte Inn Med; 1989 Sep; 44(17):504-8. PubMed ID: 2686226
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An antihypertensive drug with polyfactor mechanism of action: urapidil.
    Van Zwieten PA; Prichard BN
    Ann Fr Anesth Reanim; 1989; 8(5):568-71, 528-31. PubMed ID: 2627052
    [No Abstract]   [Full Text] [Related]  

  • 58. The relevance of serotonin antagonism in the treatment of hypertension.
    Doyle AE
    Drugs; 1988; 36 Suppl 1():67-73. PubMed ID: 3240730
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [What does the introduction of ketanserin for the treatment of arterial hypertension represent?].
    Rorive G; Carlier PG; Krzesinski JM
    Rev Med Liege; 1988 Mar; 43 Suppl 1():50-4. PubMed ID: 3375650
    [No Abstract]   [Full Text] [Related]  

  • 60. [Marginal notes on ketanserin].
    van der Pol JM; Oei TT
    Ned Tijdschr Geneeskd; 1989 Jan; 133(2):82-3. PubMed ID: 2915731
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.